PureHealth Holding, the largest healthcare group in the Middle East, has announced its proposal for its first-ever dividend distribution since its listing on the Abu Dhabi Securities Exchange (ADX) in December 2023. The Board of Directors has recommended a total dividend of Dh343 million (Dh3.09 fils per share) for the 2024 financial year, representing 20 percent of the Group’s net profit. Shareholders will vote on the proposal at the upcoming Annual General Meeting (AGM) on April 9.
This announcement follows PureHealth’s completion of its first full financial year as a publicly listed company. The proposed dividend underscores the Group’s financial strength, its ability to generate shareholder returns, and its commitment to growth while maintaining a solid capital position. The remaining profits will be retained to support future expansion plans, including potential global opportunities, according to a company statement.
PureHealth concluded the 2024 financial year with a strong financial performance, reporting revenues of Dh25.8 billion, Ebitda of Dh4.1 billion, and a net profit of Dh1.7 billion. The Group also maintains a substantial cash position of Dh11.9 billion and a low leverage ratio of approximately 0.1x, providing ample financial flexibility for future strategic initiatives. Operating within the resilient healthcare sector, PureHealth is well-positioned to pursue its ambitious growth and acquisition agenda, further solidifying its regional and global presence.
As part of its expansion strategy, PureHealth recently acquired a 60 percent stake in Hellenic Healthcare Group from the global private equity firm CVC, which will remain a minority partner. The acquisition aligns with PureHealth’s focus on enhancing its global footprint and driving operational excellence across its international healthcare network.
The proposed dividend marks a significant milestone in PureHealth’s journey as a publicly traded company, reflecting its strong financial standing and dedication to shareholder value. If approved at the AGM, the dividend distribution will highlight the Group’s ability to generate consistent returns while maintaining a robust position in the market. The move is expected to bolster investor confidence as the company continues to expand its influence in the global healthcare industry.
